Citigroup
RIGL icon

Citigroup’s Rigel Pharmaceuticals RIGL Stock Holding History

Citigroup’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,000
Closed -$150K – 6586
2022
Q1 		$150K Buy
+5,000
New +$135K ﹤0.01% 4226
2021
Q1 		– Sell
-120
Closed -$4K – 7184
2020
Q4 		$4K Sell
120
-210
-64% -$6.08K ﹤0.01% 7159
2020
Q3 		$8K Buy
330
+130
+65% +$3.19K ﹤0.01% 6775
2020
Q2 		$4K Sell
200
-190
-49% -$3.42K ﹤0.01% 7320
2020
Q1 		$6K Sell
390
-10
-3% -$213 ﹤0.01% 7236
2019
Q4 		$9K Buy
+400
New +$8.24K ﹤0.01% 7240
2019
Q1 		– Sell
-760
Closed -$17K – 7771
2018
Q4 		$17K Buy
760
+120
+19% +$3.39K ﹤0.01% 6956
2018
Q3 		$21K Buy
640
+450
+237% +$13.5K ﹤0.01% 7063
2018
Q2 		$5K Buy
190
+30
+19% +$1.07K ﹤0.01% 7357
2018
Q1 		$6K Buy
160
+10
+7% +$400 ﹤0.01% 7172
2017
Q4 		$6K Sell
150
-260
-63% -$9.89K ﹤0.01% 7195
2017
Q3 		$10K Buy
410
+90
+28% +$2.19K ﹤0.01% 6698
2017
Q2 		$9K Sell
320
-100
-24% -$2.74K ﹤0.01% 6573
2017
Q1 		$14K Buy
420
+320
+320% +$8.15K ﹤0.01% 6428
2016
Q4 		$2K Buy
+100
New +$2.86K ﹤0.01% 7066

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's RIGL Position: Q2 2026 in Review

Citigroup increased its Rigel Pharmaceuticals (RIGL) stake by 578% in Q2 2026, buying an estimated $856K and bringing the position to 32,566 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3278.

Citigroup first reported a position in RIGL in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.5M in Q1 2018. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Citigroup held 32,566 shares of Rigel Pharmaceuticals worth $1.27M as of Q2 2026.
  • Citigroup bought 27,765 Rigel Pharmaceuticals shares in Q2 2026, an estimated $856K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3278 holding.
  • Citigroup first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Rigel Pharmaceuticals position peaked at $3.5M in Q1 2018.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.